Markets:

Overview

News

Currencies

International

Treasuries

La-Z-Boy Incorporated Common Stock (NY:LZB)

33.85 -6.98 (-17.10%)

Streaming Delayed Price Updated: 3:47 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about La-Z-Boy Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why La-Z-Boy Stock Jumped 14% This Past Week ↗

February 25, 2023

CEO Melinda Whittington sees a path to increased market share.

Via The Motley Fool

La-Z-Boy Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗

February 23, 2023

On Thursday, La-Z-Boy stock saw a positive improvement to its Relative Strength (RS) Rating, rising to 90 from 77 a day earlier.

Via Investor's Business Daily

Why La-Z-Boy Shares Are Booming Today ↗

February 22, 2023

La-Z-Boy Inc. (NYSE: LZB) shares are trading higher on Wednesday after the company reported better-than-expected third-quarter results.

Via Benzinga

11 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

February 22, 2023

Via Benzinga

Why La-Z-Boy Stock Was Having a Busy Wednesday ↗

February 22, 2023

Robust sales are fueling strong profits.

Via The Motley Fool

Furniture Stocks: A Comfortable Way To Ride Out The Storm

February 22, 2023

Furniture companies like Ethan Allen Interiors, Haverty Furniture Companies and La-Z-Boy are a comfortable place to ride out the economic storm.

Via MarketBeat

Topics Economy World Trade

Looking Into La-Z-Boy's Return On Invested Capital ↗

February 22, 2023

Via Benzinga

Earnings Outlook For La-Z-Boy ↗

February 20, 2023

Via Benzinga

La-Z-Boy's Return on Invested Capital Overview ↗

December 29, 2022

Via Benzinga

Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 22, 2023

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous...

Via Benzinga

Wingstop, La-Z-Boy, Palo Alto Networks And Other Big Stocks Moving Higher On Wednesday ↗

February 22, 2023

U.S. stocks traded slightly lower, with the Dow Jones dropping around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

La-Z-Boy's Earnings: A Preview ↗

November 29, 2022

Via Benzinga

US Stocks Edge Higher; TJX Posts Upbeat Sales ↗

February 22, 2023

U.S. stocks traded slightly higher this morning, with the Dow Jones gaining 0.1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.09% to 33,157.87 while the NASDAQ rose 0.32%...

Via Benzinga

TJX, Baidu And 3 Stocks To Watch Heading Into Wednesday ↗

February 22, 2023

With US futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

La-Z-Boy Reclines To More Comfortable Levels

December 01, 2022

La-Z-Boy is down following the Q3 guidance but this is an opportunity for value-loving income investors to take advantage of.

Via MarketBeat

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session ↗

November 30, 2022

Via Benzinga

Earnings Scheduled For November 30, 2022 ↗

November 30, 2022

Companies Reporting Before The Bell • Seadrill (NYSE:SDRL) is expected to report earnings for its third quarter. • Build-A-Bear Workshop (NYSE:BBW) is likely to report earnings for its third quarter.

Via Benzinga

Wayfair Still Has Its Fair Share of Issues

November 15, 2022

It may seem tempting to declare Wayfair a potential 2023 turnaround story, but plenty of headwinds remain - including a slowdown in U.S. e-commerce activity.

Via MarketBeat

Topics Initial Public Offering

The Institutions Are Comfortable With The Furniture Industry

November 01, 2022

Furniture stocks are tightly held names that are still offering value and yield to investors, and they are outperforming expectations.

Via MarketBeat

Ranking the 7 Top Small-Cap Stocks to Buy From Best to Worst ↗

October 24, 2022

Although blue chips provide greater predictability, these top small-cap stocks to buy may drive intense growth for speculators.

Via InvestorPlace

These REITs With Yields Higher Than The Risk-Free Rate May Hedge Against Inflation ↗

October 01, 2022

Real estate investment trusts (REITs) have been beaten down since the start of the year, but now may be the perfect time to open a position in one.

Via Benzinga

Sidoti's September Small-Cap Virtual Conference

September 20, 2022

Via ACCESSWIRE

La-Z-Boy's Return on Invested Capital Insights ↗

September 13, 2022

According to Benzinga Pro, during Q1, La-Z-Boy (NYSE:LZB) earned $38.94 million, a 32.42% increase from the preceding quarter. La-Z-Boy's sales decreased to $604.09 million, a 11.76% change since Q4.

Via Benzinga

Monday Is Your Last Chance To Buy La-Z-Boy Before The Dividend Payout ↗

September 01, 2022

Monday marks the last chance for investors to receive the next dividend payout from La-Z-Boy (NYSE:LZB).

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

August 24, 2022

Via Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

August 23, 2022

Gainers

Via Benzinga

Earnings Scheduled For August 23, 2022 ↗

August 23, 2022

Companies Reporting Before The Bell • Regis (NYSE:RGS) is estimated to report earnings for its fourth quarter. • Jianpu Technology (NYSE:JT) is likely to report earnings for its second quarter.

Via Benzinga

Earnings Outlook For La-Z-Boy ↗

August 22, 2022

La-Z-Boy (NYSE:LZB) is set to give its latest quarterly earnings report on Tuesday, 2022-08-23. Here's what investors need to know before the announcement. Analysts estimate that La-Z-Boy will report...

Via Benzinga

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.